Bank of America’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
136,215
-296,125
-68% -$4.38M ﹤0.01% 4345
2025
Q4
$13.2M Buy
432,340
+234,633
+119% +$6.27M ﹤0.01% 2636
2025
Q3
$3.93M Buy
197,707
+125,462
+174% +$2.2M ﹤0.01% 4240
2025
Q2
$1.05M Buy
72,245
+10,687
+17% +$151K ﹤0.01% 5272
2025
Q1
$753K Buy
+61,558
New +$1.15M ﹤0.01% 5426

Other funds holding BBNX

Bank of America's BBNX Position: Q1 2026 in Review

Bank of America reduced its Beta Bionics (BBNX) stake by 68% in Q1 2026, selling an estimated $4.38M and leaving 136,215 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4345.

Bank of America first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.2M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Bank of America held 136,215 shares of Beta Bionics worth $1.36M as of Q1 2026.
  • Bank of America sold 296,125 Beta Bionics shares in Q1 2026, an estimated $4.38M.
  • Beta Bionics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4345 holding.
  • Bank of America first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Bank of America's Beta Bionics position peaked at $13.2M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.